Retinal toxicity of intravitreal sparfloxacin, ofloxacin, and imipenem in a rabbit model

Journal of Toxicology - Cutaneous and Ocular Toxicology

Volumn 18, Issue 1, 1999, Pages 65-73

  Smith, Miriam A ^a,d   D'Aversa, Gerard ^a   Sable, Michael ^a   Farbowitz, Michael ^a   Sorenson, John ^b   Green, W Richard ^c  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b VITREOUS RETINA MACULA CONSULTANTS OF NEW YORK   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; OFLOXACIN; SPARFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG SAFETY; ENDOPHTHALMITIS; EYE TOXICITY; FEMALE; HISTOPATHOLOGY; INTRAVITREAL DRUG ADMINISTRATION; NONHUMAN; RABBIT; RETINA INJURY; UVEITIS;

ANIMALIA; CHAMAESARACHA; ORYCTOLAGUS CUNICULUS;

EID: 0032907771     PISSN: 07313829     EISSN: None     Source Type: Journal    
DOI: 10.3109/15569529909049324     Document Type: Article

References (10)

1. I. Brook and E. H. Frazier, Infections caused by Propionibacterium species, Rev. Infect. Dis. 13: 819-822, 1991.
2. E. J. C. Goldstein and D. M. Citron, Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-900, and WIN 57273 against anaerobic bacteria, Antimicrob. Agents Chemother. 36: 1158-1162, 1992.
3. M. A. Smith, P. Alperstein, K. France, E. M. Vellozzi, and H. D. Isenberg, Susceptibility testing of Propionibacterium acnes comparing agar dilution with E test, J. Clin. Microbiol. 34: 1024-1026, 1996.
4. M. A. Smith, J. A. Sorenson, G. D'Aversa, S. Mandelbaum, I. Udell, and W. Harrison, Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and dexamethasone, J. Infect. Dis. 175: 462-466, 1997.
5. K. Kawasaki, K. Mochizuki, M. Torisaki, Y. Yamashita, Y. Shirao, K. Wakabayashi, and J. Tanabe, Electroretinographical changes due to antimicrobials, Lens Eye Toxic. Res. 7: 693-704, 1990.
6. K. Mochizuki, M. Torisaki, Y. Yamashita, Y. Shirao, and T. Sasaki, Effects of vancoymycin and ofloxacin on rabbit ERG in vivo, Nippon Ganka Gakkai Zasshi 93: 322-328, 1989.
7. S. X. Stevens, B. D. Fouraker, and H. G. Jensen, Intraocular safety of ciprofloxacin, Arch. Ophthalmol. 109: 1737-1743, 1991.
8. I. Cochereau-Massin, J. Bauchet, S. Marrakchi-Benjaafar, A. Saleh-Mghir, F. Faurisson, J. M. Vallois, E. Vallee, and J. J. Pocidalo, Efficacy and ocular penetration of sparfloxacin in experimental streptococcal endophthalmitis,Antimicrob. Agents Chemother. 37: 633-636, 1993.
9. A. Madu, W. Liu, R. Perkins, R. Aswani, G. Drusano, M. Mayers, U. Mian, C. Madu, and M. H. Miller, Influence of physiochemical properties on ocular penetration of quionolones ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin following systemic administration, ARVO abstracts, Invest. Ophthalmol. Vis. Sci. 36: S1018, 1995.
10. P. G. Davey, M. Barza, and M. Stuart, Dose response of experimental Pseudomonas endophthalmitis to ciprofloxacin, gentamicin, and imipenem: evidence for resistance to "late" treatment of infections, J. Infect. Dis. 155: 518-523, 1987.